查找临床试验
已按「银屑病」检索，对应国际通用词 psoriasis
共找到 47 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 22:08，每 5 分钟自动同步A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
United States、Argentina、Australia、Brazil、Bulgaria 等 12 国
年龄 18 Years – 不限
Janssen Research & Development, LLC
A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
China
年龄 18 Years – 70 Years
Chipscreen Biosciences, Ltd.
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
China
年龄 18 Years – 70 Years
Zhejiang Wenda Pharma Technology LTD.
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
China
年龄 18 Years – 55 Years
Usynova Pharmaceuticals Ltd.
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
China
年龄 18 Years – 70 Years
Beijing InnoCare Pharma Tech Co., Ltd.
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
United States、Argentina、Belgium、Brazil、Canada 等 12 国
年龄 12 Years – 17 Years
Bristol-Myers Squibb
Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
China
年龄 18 Years – 75 Years
Shanghai Huaota Biopharmaceutical Co., Ltd.
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
United States、Australia、China、Croatia、Czechia 等 12 国
年龄 18 Years – 不限
Takeda
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of HRS-4139 in Healthy Participants
China
年龄 18 Years – 55 Years
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis
China
年龄 18 Years – 不限
Guangdong Hengrui Pharmaceutical Co., Ltd
Preventing Structural Damage in Early Psoriatic Arthritis
Hong Kong
年龄 18 Years – 不限
Chinese University of Hong Kong
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
United States、Argentina、Australia、Belgium、Brazil 等 12 国
年龄 3 Years – 不限
Janssen Research & Development, LLC